Orloff J J, Ganz M B, Nathanson M H, Moyer M S, Kats Y, Mitnick M, Behal A, Gasalla-Herraiz J, Isales C M
Division of Endocrinology and Metabolism, Veterans Affairs Connecticut Healthcare System, West Haven 06516, USA.
Endocrinology. 1996 Dec;137(12):5376-85. doi: 10.1210/endo.137.12.8940360.
A midregion fragment of PTH-related protein (PTHrP), which is intensively conserved across species, has been identified as a secretory product of several different cell types, including keratinocytes and squamous carcinomas. As recent data suggest that a midregion PTHrP fragment may be biologically active, we hypothesized that midregion PTHrPs interact with unique cell surface receptors that mediate autocrine or paracrine action. Dose-dependent transient elevations in intracellular calcium ([Ca2-]i) were observed in fura-2-loaded SqCC/Y1 squamous carcinoma cells exposed to human (h) PTHrP-(67-86)NH2, [Tyr36]hPTHrP-(1-36)NH2, and hPTHrP-(1-141) at concentrations ranging from 1 pM to 1 microM. The effects of maximal stimulatory concentrations of [Tyr36]PTHrP-(1-36)NH2 and PTHrP-(67-86)NH2 on [Ca2+]i were additive. The inhibitory PTH analog, [D-Trp12,Tyr34]bovine PTH-(7-34)NH2, attenuated the [Ca2+]i response to [Tyr36]hPTHrP-(1-36)NH2, but not that to PTHrP-(67-86)NH2. These data suggest that PTHrP-(67-86)NH2 activates a different receptor pathway in SqCC/Y1 cells from the one activated by [Tyr36]hPTHrP-(1-36)NH2. Radiolabeled PTHrP-(67-86)NH2 did not bind to SqCC/Y1 cells, and PTHrP-(67-86)NH2 did not compete for binding of 125I-labeled [Tyr36]PTHrP-(1-36)NH2 to PTH/PTHrP receptors on SaOS-2 osteosarcoma cells. Activation of the phospholipase C pathway by PTHrP-(67-86)NH2 was confirmed by exposing SqCC/Y1 cells to peptide for 1 min and measuring the accumulation of inositol trisphosphates. PTHrP-(67-86)NH2 treatment (100 nM) resulted in maximal stimulation of inositol trisphosphates of 3.1 +/- 0.1-fold over the control value, with an EC50 of 1.5 +/- 1.2 nm. In contrast, PTHrP-(67-86)NH2 (0.1 nM to 1 microM) did not stimulate adenylyl cyclase in SqCC/Y1 cells despite vigorous stimulation of cAMP formation by isoproterenol (1 microM) to 66-fold over the basal value. To determine whether messenger RNA (mRNA) prepared from SqCC/Y1 cells would direct the translation of a receptor protein that mediated a [Ca2+]i response to PTHrP-(67-86)NH2, we performed expression studies in Xenopus oocytes. Fluo-3 fluorescence in Xenopus oocytes expressing SqCC/Y1 mRNA was visualized by confocal video microscopy after exposure to 1 microM PTHrP-(67-86)NH2. Clear increases in [Ca2+]i were detected in mRNA-injected, but not in sham-injected, oocytes. Finally, we examined the effect of PTHrP-(67-86)NH2 treatment on fibronectin secretion from SqCC/YN1 cells. A significant 3.5-fold increase in fibronectin secretion into conditioned medium was observed when SqCC/Y1 cells were exposed to 100 nM PTHrP-(67-86)NH2, and this effect was dose dependent, with an EC50 of 0.1 nM. We conclude that PTHrP-(67-86)NH2 activates phospholipase C-dependent pathways in SqCC/Y1 cells through a receptor distinct from that activated by PTHrP-(1-36) in the same cells. As a midregion secretory fragment of PTHrP has been partially purified from several different cell types, this receptor may have broad biological significance.
甲状旁腺激素相关蛋白(PTHrP)的中间区域片段在物种间高度保守,已被确定为几种不同细胞类型(包括角质形成细胞和鳞状细胞癌)的分泌产物。近期数据表明,中间区域的PTHrP片段可能具有生物活性,我们推测中间区域的PTHrP与介导自分泌或旁分泌作用的独特细胞表面受体相互作用。在暴露于浓度范围为1 pM至1 μM的人(h)PTHrP-(67 - 86)NH2、[Tyr36]hPTHrP-(1 - 36)NH2和hPTHrP-(1 - 141)的fura-2负载的SqCC/Y1鳞状细胞癌中,观察到细胞内钙([Ca2+]i)呈剂量依赖性短暂升高。[Tyr36]PTHrP-(1 - 36)NH2和PTHrP-(67 - 86)NH2的最大刺激浓度对[Ca2+]i的影响是相加的。抑制性甲状旁腺激素类似物 [D-Trp12,Tyr34]牛甲状旁腺激素-(7 - 34)NH2减弱了对[Ca2+]i的反应至 [Tyr36]hPTHrP-(1 - 36)NH2,但对PTHrP-(67 - 86)NH2没有减弱作用。这些数据表明,PTHrP-(67 - 86)NH2在SqCC/Y1细胞中激活的受体途径与 [Tyr36]hPTHrP-(1 - 36)NH2激活的不同。放射性标记的PTHrP-(67 - 86)NH2不与SqCC/Y1细胞结合,且PTHrP-(67 - 86)NH2不竞争125I标记的 [Tyr36]PTHrP-(1 - 36)NH2与SaOS-2骨肉瘤细胞上的PTH/PTHrP受体的结合。通过将SqCC/Y1细胞暴露于该肽1分钟并测量肌醇三磷酸的积累,证实了PTHrP-(67 - 86)NH2对磷脂酶C途径的激活。PTHrP-(67 - 86)NH2处理(100 nM)导致肌醇三磷酸最大刺激至对照值的3.1 ± 0.1倍,EC50为1.5 ± 1.2 nM。相比之下,尽管异丙肾上腺素(1 μM)将cAMP形成强烈刺激至基础值的66倍,但PTHrP-(67 - 86)NH2(0.1 nM至1 μM)在SqCC/Y1细胞中未刺激腺苷酸环化酶。为了确定从SqCC/Y1细胞制备的信使核糖核酸(mRNA)是否会指导介导对PTHrP-(67 - 86)NH2的[Ca2+]i反应的受体蛋白的翻译,我们在非洲爪蟾卵母细胞中进行了表达研究。在暴露于1 μM PTHrP-(67 - 86)NH2后,通过共聚焦视频显微镜观察表达SqCC/Y1 mRNA的非洲爪蟾卵母细胞中的Fluo-3荧光。在注射mRNA的卵母细胞中检测到[Ca2+]i明显增加,但在假注射的卵母细胞中未检测到。最后,我们研究了PTHrP-(67 - 86)NH2处理对SqCC/YN1细胞中纤连蛋白分泌的影响。当SqCC/Y1细胞暴露于100 nM PTHrP-(67 - 86)NH2时,观察到条件培养基中纤连蛋白分泌显著增加3.5倍,且这种作用是剂量依赖性的,EC50为0.1 nM。我们得出结论,PTHrP-(67 - 86)NH2通过与同一细胞中PTHrP-(1 - 36)激活的受体不同的受体激活SqCC/Y1细胞中依赖磷脂酶C的途径。由于已从几种不同细胞类型中部分纯化了PTHrP的中间区域分泌片段,该受体可能具有广泛的生物学意义。